Fatal Peripartum Cardiomyopathy after Bupivacaine Local Injection in Elective Cesarean Section: A Case Report.
- Author:
Jin Yong PARK
1
;
Hwa Rim KANG
;
Jee Hyun KIM
;
Hyung Woo KIM
;
Sang Min KIM
;
You Jin CHANG
;
Kang Hyeon CHOE
;
Ki Man LEE
;
Jin Young AN
Author Information
1. The Department of Internal Medicine, College of Medicine, Chungbuk National University Hospital, Cheongju, Korea. drahnjy@chungbuk.ac.kr
- Publication Type:Case Report
- Keywords:
Bupivacaine;
Cardiomyopathy;
Lipid rescue
- MeSH:
Anesthesia, Local;
Bupivacaine*;
Cardiomyopathies*;
Cardiotoxicity;
Central Nervous System;
Cesarean Section*;
Emergencies;
Female;
Humans;
Peripartum Period*;
Pregnancy
- From:Journal of the Korean Society of Emergency Medicine
2016;27(2):214-218
- CountryRepublic of Korea
- Language:English
-
Abstract:
Bupivacaine is frequently used for pain control and local anesthesia. However, it is associated with certain acute and fatal side effects, although rare, including cardiac and central nervous system toxicities. In particular, bupivacaine-induced cardiac toxicity may be fatal. This condition can be diagnosed as bupivacaine-induced cardiotoxicity by excluding other causes and determining a history of bupivacaine administration. However, in emergency situations, recognizing bupivacaine toxicity can be difficult due to the physician's lack of awareness regarding the condition or in the absence of clear communication regarding the patient's medical history. In the current case report, we describe our experience with strong suspected bupivacaine-induced cardiotoxicity in a patient who underwent cesarean section along with a review of the literature.
